Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: UVEAL MELANOMA, . Treffer: 41

2021

Reschke, M; Biewald, E; Bronstein, L; Brecht, IB; Dittner-Moormann, S; Driever, F; Ebinger, M; Fleischhack, G; Grabow, D; Geismar, D; Göricke, S; Guberina, M; Le Guin, CHD; Kiefer, T; Kratz, CP; Metz, K; Müller, B; Ryl, T; Schlamann, M; Schlüter, S; Schönberger, S; Schulte, JH; Sirin, S; Süsskind, D; Timmermann, B; Ting, S; Wackernagel, W; Wieland, R; Zenker, M; Zeschnigk, M; Reinhardt, D; Eggert, A; Ritter-Sovinz, P; Lohmann, DR; Bornfeld, N; Bechrakis, N; Ketteler, P Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria.
Cancers (Basel). 2021; 13(8): 1876 Doi: 10.3390/cancers13081876 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Steeb, T; Wessely, A; Alter, M; Bayerl, C; Bender, A; Bruning, G; Dabrowski, E; Debus, D; Devereux, N; Dippel, E; Drexler, K; Dücker, P; Dummer, R; Emmert, S; Elsner, P; Enk, A; Gebhardt, C; Gesierich, A; Goebeler, M; Goerdt, S; Goetze, S; Gutzmer, R; Haferkamp, S; Hansel, G; Hassel, JC; Heinzerling, L; Kähler, KC; Kaume, KM; Krapf, W; Kreuzberg, N; Lehmann, P; Livingstone, E; Löffler, H; Loquai, C; Mauch, C; Mangana, J; Meier, F; Meissner, M; Moritz, RKC; Maul, LV; Müller, V; Mohr, P; Navarini, A; Van Nguyen, A; Pfeiffer, C; Pföhler, C; Posch, C; Richtig, E; Rompel, R; Sachse, MM; Sauder, S; Schadendorf, D; Schatton, K; Schulze, HJ; Schultz, E; Schilling, B; Schmuth, M; Simon, JC; Streit, M; Terheyden, P; Thiem, A; Tüting, T; Welzel, J; Weyandt, G; Wesselmann, U; Wollina, U; Ziemer, M; Zimmer, L; Zutt, M; Berking, C; Schlaak, M; Heppt, MV; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma) Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
J Cancer Res Clin Oncol. 2021; 147(6):1763-1771 Doi: 10.1007/s00432-020-03450-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Steiner, B; Wackernagel, W; Vajda, L; Georgi, T; Langmann, G Gamma knife radiosurgery in ophthalmic oncology.
SPEKTRUM AUGENHEILKD. 2020; 34(4): 100-106. Doi: 10.1007/s00717-020-00447-5
Web of Science FullText FullText_MUG

 

2018

Walpole, S; Pritchard, AL; Cebulla, CM; Pilarski, R; Stautberg, M; Davidorf, FH; de la Fouchardière, A; Cabaret, O; Golmard, L; Stoppa-Lyonnet, D; Garfield, E; Njauw, CN; Cheung, M; Turunen, JA; Repo, P; Järvinen, RS; van Doorn, R; Jager, MJ; Luyten, GPM; Marinkovic, M; Chau, C; Potrony, M; Höiom, V; Helgadottir, H; Pastorino, L; Bruno, W; Andreotti, V; Dalmasso, B; Ciccarese, G; Queirolo, P; Mastracci, L; Wadt, K; Kiilgaard, JF; Speicher, MR; van Poppelen, N; Kilic, E; Al-Jamal, RT; Dianzani, I; Betti, M; Bergmann, C; Santagata, S; Dahiya, S; Taibjee, S; Burke, J; Poplawski, N; O'Shea, SJ; Newton-Bishop, J; Adlard, J; Adams, DJ; Lane, AM; Kim, I; Klebe, S; Racher, H; Harbour, JW; Nickerson, ML; Murali, R; Palmer, JM; Howlie, M; Symmons, J; Hamilton, H; Warrier, S; Glasson, W; Johansson, P; Robles-Espinoza, CD; Ossio, R; de Klein, A; Puig, S; Ghiorzo, P; Nielsen, M; Kivelä, TT; Tsao, H; Testa, JR; Gerami, P; Stern, MH; Paillerets, BB; Abdel-Rahman, MH; Hayward, NK Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
JNCI-J NATL CANCER I. 2018; 110(12): 1328-1341. Doi: 10.1093/jnci/djy171 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Möller, I; Murali, R; Müller, H; Wiesner, T; Jackett, LA; Scholz, SL; Cosgarea, I; van de Nes, JA; Sucker, A; Hillen, U; Schilling, B; Paschen, A; Kutzner, H; Rütten, A; Böckers, M; Scolyer, RA; Schadendorf, D; Griewank, KG Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Mod Pathol. 2017; 30(3):350-356 Doi: 10.1038/modpathol.2016.201 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tarmann, L; Wackernagel, W; Ivastinovic, D; Schneider, M; Winkler, P; Langmann, G Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
PLoS One. 2017; 12(8): e0183833-e0183833. Doi: 10.1371/journal.pone.0183833 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Schwab, C; Wackernagel, W; Grinninger, P; Mayer, C; Schwab, K; Langmann, G; Richtig, E; Wedrich, A; Hofmann-Wellenhof, R; Zalaudek, I A Unifying Concept of Uveal Pigment Cell Distribution and Dissemination Based on an Animal Model: Insights into Ocular Melanogenesis.
Cells Tissues Organs. 2016; 201(3):232-8 Doi: 10.1159/000443877
Web of Science PubMed FullText FullText_MUG

 

van de Nes, J; Gessi, M; Sucker, A; Möller, I; Stiller, M; Horn, S; Scholz, SL; Pischler, C; Stadtler, N; Schilling, B; Zimmer, L; Hillen, U; Scolyer, RA; Buckland, ME; Lauriola, L; Pietsch, T; Waha, A; Schadendorf, D; Murali, R; Griewank, KG Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
J NEURO-ONCOL. 2016; 127(3): 435-444. Doi: 10.1007/s11060-015-2052-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Jahn, SW; Kashofer, K; Halbwedl, I; Winter, G; El-Shabrawi-Caelen, L; Mentzel, T; Hoefler, G; Liegl-Atzwanger, B Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Mod Pathol. 2015; 28(7):895-903 Doi: 10.1038/modpathol.2015.39 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwab, C; Zalaudek, I; Mayer, C; Riedl, R; Wackernagel, W; Juch, H; Aigner, B; Brunasso, AM; Langmann, G; Richtig, E New insights into oculodermal nevogenesis and proposal for a new iris nevus classification.
Br J Ophthalmol. 2015; 99(5):644-649 Doi: 10.1136/bjophthalmol-2014-305849
Web of Science PubMed FullText FullText_MUG

 

Tarmann, L; Wackernagel, W; Avian, A; Mayer, C; Schneider, M; Winkler, P; Langmann, G Ruthenium-106 plaque brachytherapy for uveal melanoma.
Br J Ophthalmol. 2015; 99(12):1644-1649 Doi: 10.1136/bjophthalmol-2015-306666
Web of Science PubMed FullText FullText_MUG

 

2013

Griewank, KG; Westekemper, H; Murali, R; Mach, M; Schilling, B; Wiesner, T; Schimming, T; Livingstone, E; Sucker, A; Grabellus, F; Metz, C; Süsskind, D; Hillen, U; Speicher, MR; Woodman, SE; Steuhl, KP; Schadendorf, D Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Clin Cancer Res. 2013; 19(12):3143-3152 Doi: 10.1158/1078-0432.CCR-13-0163 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Murali, R; Wiesner, T; Scolyer, RA Tumours associated with BAP1 mutations.
Pathology. 2013; 45(2):116-126 Doi: 10.1097/PAT.0b013e32835d0efb
Web of Science PubMed FullText FullText_MUG

 

Oswald, W; Mayer, C; Tarmann, L; Langmann, G; Wackernagel, W; PROCHORN - Prospective Register of female Patients with Retinal Nevi.
SPEKTRUM AUGENHEILKD. 2013; 27(6): 299-304. Doi: 10.1007/s00717-013-0192-3
Web of Science FullText FullText_MUG

 

2010

Langmann, G A short historical review about Leksell Gamma Knife Radiosurgery (LGR) for uveal melanomas
SPEKTRUM AUGENHEILKD. 2010; 24(1): 6-10. Doi: 10.1007/s00717-010-0381-2
Web of Science FullText FullText_MUG

 

Van Raamsdonk, CD; Griewank, KG; Crosby, MB; Garrido, MC; Vemula, S; Wiesner, T; Obenauf, AC; Wackernagel, W; Green, G; Bouvier, N; Sozen, MM; Baimukanova, G; Roy, R; Heguy, A; Dolgalev, I; Khanin, R; Busam, K; Speicher, MR; O'Brien, J; Bastian, BC Mutations in GNA11 in Uveal Melanoma.
N ENGL J MED. 2010; 363(23): 2191-2199. Doi: 10.1056/NEJMoa1000584 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Hofmann, UB; Kauczok-Vetter, CS; Houben, R; Becker, JC Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Clin Cancer Res. 2009; 15(1):324-329 Doi: 10.1158/1078-0432.CCR-08-2243 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Mayer, CF; Langmann, G; Wackernagel, W; Schneider, M; Wedrich, A Bulbuserhalt und Funktion nach Endoresektion und Gamma-Knife Radiochirurgie uvealer Melanome
Spektrum der Augenheilkunde. 2009; 23: 347-352. Doi: 10.1007/s00717-009-0354-5
Web of Science FullText FullText_MUG

 

Wackernagel, W; Schneider, M; Mayer, CF; Langmann, G; Singh, AD Genetik des Aderhautmelanoms
Spektrum der Augenheilkunde. 2009; 23: 319-332. Doi: 10.1007/s00717-009-0360-7
Web of Science FullText FullText_MUG

 

2008

Hahn, S; Ugurel, S; Hanschmann, KM; Strobel, H; Tondera, C; Schadendorf, D; Löwer, J; Löwer, R Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability.
AIDS Res Hum Retroviruses. 2008; 24(5):717-723 Doi: 10.1089/aid.2007.0286
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Langmann, G; Schmutzer, M; Mattes, D; Wedrich, A Endoresektion von vorbestrahlten Aderhautmelanomen als Therapie einer persistierenden Amotio mit (beginnendem) Neovaskularisationsglaukom.
Spektrum der Augenheilkunde. 2007; 21(3): 179-182. Doi: 10.1007/s00717-007-0206-0
Web of Science FullText FullText_MUG

 

Mossböck, G; Rauscher, T; Winkler, P; Kapp, KS; Langmann, G Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.
Strahlenther Onkol. 2007; 183(10):571-575 Doi: 10.1007/s00066-007-1734-x
Web of Science PubMed FullText FullText_MUG

 

2006

Richtig, E; Langmann, G; Schlemmer, G; Müllner, K; Papaefthymiou, G; Bergthaler, P; Smolle, J Safety and efficacy of interferon alfa-2b in the adjuvant treatment of uveal melanoma
OPHTHALMOLOGE. 2006; 103(6): 506-511. Doi: 10.1007/s00347-006-1350-7
Web of Science PubMed FullText FullText_MUG

 

2005

Ardjomand, N; Komericki, P; Langmann, G; Mattes, D; Moray, M; Scarpatetti, M; El-Shabrawi, Y Lymph node metastases arising from uveal melanoma.
Wien Klin Wochenschr. 2005; 117(11-12):433-435 Doi: 10.1007/s00508-005-0329-8
Web of Science PubMed FullText FullText_MUG

 

Boldin, I; Langmann, G; Richtig, E; Schwantzer, G; Ardjomand, N; Wegscheider, B; El-Shabrawi, Y Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients.
MELANOMA RES. 2005; 15(6): 503-507. Doi: 10.1097/00008390-200512000-00004
Web of Science PubMed FullText FullText_MUG

 

Langmann, G; Lechner, H; Wenzel, E; Mossböck, G; Wackernagel, W Transpupillary thermotherapy (TTT) for uveal melanomas. Long term results of a single TTT with an adapter for a conventional infrared laser].
Ophthalmologe. 2005; 102(12):1162-1167 Doi: 10.1007/s00347-005-1232-4
Web of Science PubMed FullText FullText_MUG

 

2004

Chabert, S; Velikay-Parel, M; Zehetmayer, M Influence of uveal melanoma therapy on patients' quality of life: a psychological study.
Acta Ophthalmol Scand. 2004; 82(1):25-31 Doi: 10.1046/j.1600-0420.2003.0210.x
Web of Science PubMed FullText FullText_MUG

 

Langmann, G; Wackernagel, W; Stücklschweiger, G; Feichtinger, K; Papaefthymiou, G; Faulborn, J Dose-volume histogram regression analysis of uveal melanomas after single fraction gamma knife radiosurgery].
Ophthalmologe. 2004; 101(11):1111-1119 Doi: 10.1007/s00347-003-0984-y
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Langmann, G; Müllner, K; Smolle, J Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
OPHTHALMOLOGICA. 2004; 218(2): 111-114. Doi: 10.1159/000076146
Web of Science PubMed FullText FullText_MUG

 

2003

Ardjomand, N; Ardjomand, N; Schaffler, G; Radner, H; El-Shabrawi, Y Expression of somatostatin receptors in uveal melanomas.
INVEST OPHTHALMOL VISUAL SCI. 2003; 44(3): 980-987. Doi: 10.1167/iovs.02-0481 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pföhler, C; Cree, IA; Ugurel, S; Kuwert, C; Haass, N; Neuber, K; Hengge, U; Corrie, PG; Zutt, M; Tilgen, W; Reinhold, U Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
Anticancer Drugs. 2003; 14(5):337-340 Doi: 10.1097/01.cad.0000070764.25457.ce
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Becker, JC; Terheyden, P; Kampgen, E; Wagner, S; Neumann, C; Schadendorf, D; Steinmann, A; Wittenberg, G; Lieb, W; Brocker, EB Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Br J Cancer. 2002; 87(8):840-845 Doi: 10.1038/sj.bjc.6600521 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Langmann, G; Pendl, G; Müllner, K; Feichtinger, KH; Papaefthymiouaf, G High-compared with low-dose radiosurgery for uveal melanomas.
J Neurosurg. 2002; 97(5 Suppl):640-643 Doi: 10.3171/jns.2002.97.supplement_5.0640
Web of Science PubMed FullText FullText_MUG

 

2001

El-Shabrawi, Y; Ardjomand, N; Radner, H; Ardjomand, N MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
J Pathol. 2001; 194(2):201-206 Doi: 10.1002/1096-9896(200106)194:2<201::AID-PATH840>3.0.CO;2-O
Web of Science PubMed FullText FullText_MUG

 

2000

Langmann, G; Pendl, G; Klaus-Müllner, G; Papaefthymiou, G; Guss, H Gamma knife radiosurgery for uveal melanomas: an 8-year experience.
J Neurosurg. 2000; 93 Suppl 3(2):184-188 Doi: 10.3171/jns.2000.93.supplement_3.0184
Web of Science PubMed FullText FullText_MUG

 

1998

Müllner, K; Langmann, G; Pendl, G; Faulborn, J Echographic findings in uveal melanomas treated with the Leksell gamma knife.
Br J Ophthalmol. 1998; 82(2):154-158 Doi: 10.1136/bjo.82.2.154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terheyden, P; Kampgen, E; Runger, TM; Brocker, EB; Becker, JC Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature
Hautarzt. 1998; 49(10):770-773 Doi: 10.1007/s001050050823 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Wirnsberger, GH; Kleinert, R; Langmann, G; Fuchs, U Tumor-Cell Markers in Uveal Melanoma - An Immunohistochemical Study
INT J ONCOL 1997 10: 793-799. Doi: 10.3892/ijo.10.4.793
Web of Science FullText FullText_MUG

 

1995

Langmann, A; Langmann, G; Unlücerci, C; Haller, E Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators
Ophthalmologe. 1995; 92(1):76-78
PubMed

 

1994

Speicher, MR; Prescher, G; du Manoir, S; Jauch, A; Horsthemke, B; Bornfeld, N; Becher, R; Cremer, T Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.
Cancer Res. 1994; 54(14):3817-3823 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

1993

Langmann, G; Kleinert, R; Wirnsberger, GH; Faulborn, J; Faschinger, C Proliferation markers, enzyme markers and oncogene expression profile of intraocular melanoma
Ophthalmologe. 1993; 90(5): 528-532.
PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum